Key result
Melody TPV achieves 100% success in balloon dilatation for somatic growth.
Why the study?
Transcatheter pulmonary valve (TPV) replacement has been used as an alternative to surgical replacement, but limited medium-term follow-up data are available.
Observational
Answers are grounded in this paper and cite their sources.
Supports redilation feasibility for growth in Melody recipients; leaves open durability and generalizability.
BACKGROUND: TPV has been used as an alternative to surgical pulmonary valve replacement; limited medium-term follow-up data are available. AIMS: TPVs implanted locally over a 15-year period (2006-2021). METHODS: valves in the pulmonary position. RESULTS: = 24) of patients 2.7 ± 1.6y after TPV, mostly in younger men (median 18.3, range 8.1 - 49.5 y). Balloon dilatation to accommodate for somatic growth was successful in all 17 (7.3%) attempted cases. CONCLUSION: valve is competitive with other surgical and percutaneous conduits.
No takes yet. Share an insight, caveat, or question.
Cools et al. (2025) conducted an observational in Pulmonary valve replacement. Melody TPV (percutaneous pulmonary valve replacement) was evaluated on Success of balloon dilatation to accommodate for somatic growth. Percutaneous pulmonary valve replacement using the Melody TPV demonstrated successful balloon dilatation for somatic growth in all 17 attempted cases.
Synapse has enriched 10 related papers. Consider them for comparative context: